Across the Table Podcast | Healthcare Private Equity

Barry Freeman, Managing Director in Lincoln’s Healthcare Group, joins Geoff Cockrell, host of the Across The Table podcast, and McGuireWoods associate, Trey Andrews, to discuss the growing shift toward home health catalyzed by the pandemic, including the increase of joint venture relationships between hospitals and home healthcare operators. They provide insight into value-based care and the appeal of diversified models, and conclude with a look at the future of the industry and the promise of home health.

Summary

  • On January 28, 2021, Barry Freeman, Managing Director, joined the Across The Table podcast to discuss emerging models of home healthcare.

  • Lincoln International has created a Playbook to support business leaders in documenting and articulating their COVID-19 response. To request a copy, click here.

Contributor

Meet Professionals with Complementary Expertise

Related Perspectives

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More

“Leader to Leader” Series

The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More